AbbVie's Dalvance For Bacterial Skin Infection Gets FDA Approval For Pediatric Patients
Skin-Disease Focused Biotech Castle Creek Files $100M IPO
Celldex Therapeutics Raises $250M Via Equity To Support Development Of Skin Disease Candidate
Krystal Biotech's KB105 Shows Detectable, Functionally Active TGM-1 Enzyme In Genetic Skin Condition
Skin Disorder Recent News
Dr. Reddy's Lab, Fortress Biotech Ink DFD-29 Collaboration Pact For Chronic Skin Disorder
Novan's Stock Surges As SB206 Can Potentially Shorten Duration Of Contagious Skin Disease
Amryt Pharma's Oleogel-S10 Application Gets FDA Priority Review Tag for Skin Blistering Disorder
Timber Pharma Shares Jump As Mid-Stage Skin Disorder Study With TMB-001 Concludes Enrollment Early
Google Introduces Health AI Tool To Identify Skin Conditions
Cabaletta Bio's Cell Therapy In Skin Blistering Disorder Shows Favorable Safety Profile
Akari Therapeutics' Nomacopan Secures Expediated Review Tag For Blistering Skin Disorder